Best practice recommendations for the care of women experiencing the menopause published in joint statement

10 Jun 2022


The British Menopause Society, Royal College of Obstetricians and Gynaecologists and the Society for Endocrinology have produced this joint position statement to provide guidance to healthcare practitioners who offer care to women experiencing the menopause.

Best practice recommendations for healthcare professionals providing help and support to women experiencing the menopause have been issued in a joint position statement from the British Menopause Society, Royal College of Obstetricians and Gynaecologists and the Society for Endocrinology.

The statement was prepared in response to growing concerns around hormone replacement therapy (HRT) shortages and provides an expert consensus on best practice for menopause care and treatment, incorporating national and international evidence-based information. The recommendations advise an individualised approach, considering the risks and benefits of therapies as well as lifestyle choices so that women can make informed decisions about their treatment and care.

The statement advises an individualised approach in assessing women going through the menopause and emphasises the importance that women are made aware of the help and support available to them, and that they feel able to consult their GP for trusted advice. This Position Statement is intended to provide useful and accurate recommendations for professionals to guide women in finding what’s best for them.

Professor Stephanie Baldeweg, Consultant Endocrinologist and our Clinical Committee Chair said, “In recent years, the mainstream media has provoked much positive discussion over what treatments are available and what more could be done to support women going through the menopause. Some reports and headline have been conflicting, so guidance from independent expert governing bodies, through careful consideration of peer reviewed data from a wide range of high quality sources, is very much needed to empower patients, doctors, practitioners and women to make informed choices.”

The Position Statement was published in Post Reproductive Health, with an accompanying editorial co-published in Clinical Endocrinology on Friday 10 June 2022.


Share this story